BIPHENTIN Trademark

Trademark Overview

On Wednesday, May 6, 2009, a trademark application was filed for BIPHENTIN with the United States Patent and Trademark Office. The USPTO has given the BIPHENTIN trademark a serial number of 77730600. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 13, 2018. This trademark is owned by Rhodes Pharmaceuticals L.P.. The BIPHENTIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
biphentin

General Information

Serial Number77730600
Word MarkBIPHENTIN
Filing DateWednesday, May 6, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 13, 2018
Registration Number4067680
Registration DateTuesday, December 6, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 13, 2018
Primary Code005
First Use Anywhere DateTuesday, January 4, 2011
First Use In Commerce DateTuesday, January 4, 2011

Trademark Owner History

Party NameRhodes Pharmaceuticals L.P.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressCoventry, RI 02816
Party NameRhodes Pharmaceuticals L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressCoventry, RI 02816
Party NameRhodes Pharmaceuticals L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressCoventry, RI 02816

Trademark Events

Event DateEvent Description
Friday, July 13, 2018CANCELLED SEC. 8 (6-YR)
Monday, May 15, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 15, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 6, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 6, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, November 1, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 31, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, October 31, 2011ASSIGNED TO LIE
Monday, October 3, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 13, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 7, 2011USE AMENDMENT FILED
Wednesday, September 7, 2011TEAS STATEMENT OF USE RECEIVED
Saturday, June 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 10, 2011EXTENSION 3 GRANTED
Wednesday, June 8, 2011EXTENSION 3 FILED
Wednesday, June 8, 2011TEAS EXTENSION RECEIVED
Thursday, January 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2011EXTENSION 2 GRANTED
Tuesday, December 7, 2010EXTENSION 2 FILED
Wednesday, January 5, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 7, 2010TEAS EXTENSION RECEIVED
Thursday, June 10, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 8, 2010EXTENSION 1 GRANTED
Tuesday, June 8, 2010EXTENSION 1 FILED
Tuesday, June 8, 2010TEAS EXTENSION RECEIVED
Tuesday, December 8, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2009PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2009NOTICE OF PUBLICATION
Tuesday, August 11, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 11, 2009ASSIGNED TO LIE
Monday, August 3, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 1, 2009ASSIGNED TO EXAMINER
Monday, May 11, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 9, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

biphentin hyperactivity disorder adhd deficit attention preparations treatment pharmaceutical